Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

LLY - Lilly(Eli) & Co


Close
960.02
19.820   2.065%

Share volume: 2,549,154
Last Updated: Fri 30 Aug 2024 10:02:17 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$940.20
19.82
2.11%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
71%
Profitability 90%
Dept financing 25%
Liquidity 50%
Performance 70%
Company vs Stock growth
vs
Performance
5 Days
0.76%
1 Month
21.66%
3 Months
17.95%
6 Months
27.11%
1 Year
76.37%
2 Year
218.17%
Key data
Stock price
$960.02
P/E Ratio 
124.27
DAY RANGE
$940.51 - $961.00
EPS 
$8.12
52 WEEK RANGE
$513.12 - $972.53
52 WEEK CHANGE
$0.73
MARKET CAP 
912.428 B
YIELD 
0.52%
SHARES OUTSTANDING 
950.426 M
DIVIDEND
$1.30
EX-DIVIDEND DATE
08/15/2024
NEXT EARNINGS DATE
10/30/2024
BETA 
0.96
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,335,087
AVERAGE 30 VOLUME 
$3,574,512
Company detail
CEO: David Ricks
Region: US
Website: https://www.lilly.com/
Employees: 39,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.

Recent news